Process for the Preparation of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methylpropyl)-PHENOL
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/EP2007/006515, filed Jul 23, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,739,049 | Process for the Preparation of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-PROPYL)-PHENOL In force · High confidence UsedRemaining | Grünenthal GmbH | In force | High confidence | ||
| US 8,877,974 | Process for the Preparation of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methylpropyl)-PHENOL Grace period ended Nov 4, 2026 · lapse expected · Low confidence | Gruenenthal GmbH | Grace period ended Nov 4, 2026 lapse expected | Low confidence | ||
| US 10,323,040 | Process for the Preparation of 5-Fluorotryptophol In force · High confidence | Adneuris Therapeutics, Inc. | In force | High confidence | ||
| US 11,013,701 | Stable Formulation for Parenteral Administration of Tapentadol In force · High confidence | Gruenenthal GmbH | In force | High confidence | ||
| US 10,829,480 | 3-((HETERO-)ARYL)-ALKYL-8-Amino-2-OXO-1,3-Diaza-SPIRO-[4.5]-DECANE Derivatives In force · Low confidence | Grünenthal GmbH | In force | Low confidence | ||
| US 9,339,816 | Reactor Array for Producing and Analyzing Products Lapsed May 17, 2020 on the fee record High confidence | Gruenenthal GmbH | Lapsed May 17, 2020 on the fee record | High confidence | ||
| US 8,399,503 | Spirocyclic Azaindole Derivatives Lapsed Mar 19, 2021 on the fee record High confidence | Gruenenthal GmbH | Lapsed Mar 19, 2021 on the fee record | High confidence | ||
| US 8,722,086 | Dosage Form with Impeded Abuse Lapsed May 13, 2022 on the fee record High confidence | Gruenenthal GmbH | Lapsed May 13, 2022 on the fee record | High confidence | ||
| US 10,201,502 | Tamper-resistant tablet providing immediate drug release Lapsed Feb 12, 2023 on the fee record High confidence | Gruenenthal GmbH | Lapsed Feb 12, 2023 on the fee record | High confidence | ||
| US 8,008,304 | Substituted Propiolic Acid Amides and Their Use for Producing Drugs Lapsed Aug 30, 2023 on the fee record Medium confidence | Gruenenthal GmbH | Lapsed Aug 30, 2023 on the fee record | Medium confidence | ||
| 34 more records in this group · Pro | ||||||
10 of 44 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 44, including 10 expired and 1 expiring within the 18 months from Nov 22, 2026.
4 of these are in force and held by Gruenenthal GmbH.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.